Top Section
Explore Business Standard
Don’t miss the latest developments in business and finance.
The AIIMS-Delhi administration has suspended a senior stores officer after several irregularities were found in the purchase of medical goods. In an order issued on March 10 by AIIMS Director M Srinivas, senior stores officer Rakesh Sharma has been asked to remain in the New Delhi headquarters and not leave without obtaining prior permission of the competent authority. "A disciplinary proceeding is contemplated against Rakesh Sharma...therefore,...(he is placed) under suspension with immediate effect," the order said. According to sources, Sharma had been indicted in the past as well. They alleged that irregularities have been observed in the purchase of medical goods for the general store of Dr RP Centre for Ophthalmic Sciences at the All India Institute of Medical Sciences (AIIMS) and there has been corruption of around Rs 10 crore. An NGO, Janhit Abhiyan, had written to the director recently alleging Kumar has been issuing supply orders to a company, named RD Enterprises, owned
A combination of symptom and viral rebound after untreated COVID-19 infection is rare, occurring in only three per cent of study participants, an analysis of a COVID-19 trial has found. Widespread use of nirmatrelvir -- a recommended treatment for outpatients with mild to moderate COVID-19 -- has been accompanied by reports of worsening symptoms and virologic rebound after treatment completion, the researchers said. Virologic rebound has also been reported in persons who did not receive nirmatrelvir therapy, they said. However, studies that can define the frequencies of symptom and viral rebound during the natural course of COVID-19 are lacking. Researchers from Brigham and Women's Hospital in the US conducted an analysis of 563 participants receiving placebo in a trial. The study, published in the journal Annals of Internal Medicine, found that a combination of symptom and high-level viral rebound occurred in only three per cent of participants. Symptom rebound alone occurred i
Johnson and Johnson will spend USD 16.6 billion to buy cardiovascular technology company Abiomed to strengthen its medical device division. The health care giant said on Tuesday that it will pay USD 380 for each Biomed share and also provide another USD 35 per share in cash if some commercial and clinical milestones are met. Abiomed develops technology that treats coronary artery disease and heart failure.
The National Medical Commission (NMC) has advised Indian students not to enrol themselves in medical colleges in Pakistan. The public notice issued by the NMC came days after the University Grants Commission (UGC) and the All India Council for Technical Education (AICTE) through a joint advisory urged Indian students not to enrol themselves in any college or educational institution in Pakistan, failing which they will not be eligible to find a job or pursue higher education in this country. "All concerned are advised not to travel to Pakistan for pursuing Medical Education. "Any Indian national/Overseas Citizen of India who intends to take admission in MBBS/BDS or equivalent medical course in any medical college of Pakistan shall not be eligible for appearing in FMGE or seeking employment in India on the basis of educational qualifications (in any subject) acquired in Pakistan except those who had joined Pakistan degree colleges/institutions before December 2018 or later after ...